![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 12, 10362-10366, March 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom
Received for publication, September 21, 2001, and in revised form, December 20, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The twin-arginine translocation (Tat) system
mediates the transport of proteins across the bacterial plasma membrane
and chloroplast thylakoid membrane. Operating in parallel with Sec-type
systems in these membranes, the Tat system is completely different in both structural and mechanistic terms, and is uniquely able to catalyze
the translocation of fully folded proteins across coupled membranes.
TatC is an essential, multispanning component that has been proposed to
form part of the binding site for substrate precursor proteins. In this
study we have tested the importance of conserved residues on the
periplasmic and cytoplasmic face of the Escherichia coli
protein. We find that many of the mutations on the cytoplasmic face
have little or no effect. However, substitution at several positions in
the extreme N-terminal cytoplasmic region or the predicted first
cytoplasmic loop lead to a significant or complete loss of
Tat-dependent export. The mutated strains are unable to
grow anaerobically on trimethylamine N-oxide minimal media and are unable to export trimethylamine-N-oxide
reductase (TorA). The same mutants are completely unable to export a
chimeric protein, comprising the TorA signal peptide linked to green
fluorescent protein, indicating that translocation is blocked rather
than cofactor insertion into the TorA mature protein. The data point to
two essential cytoplasmic domains on the TatC protein that are
essential for export.
The twin-arginine translocation
(Tat)1 system transports
proteins across the chloroplast thylakoid membrane and the plasma membranes of a wide range of bacteria (reviewed in Refs. 1 and 2).
Working in parallel with the well characterized Sec pathway, the Tat
system uses an entirely different mechanism and has the unique ability
to transport fully folded proteins across coupled membranes (3, 4). In
general, it appears to be used primarily for the transport of proteins
that are either obliged to fold prior to translocation, or which fold
too tightly or rapidly for the Sec system to handle. Prime examples of
substrates in Escherichia coli are a range of periplasmic
proteins that acquire redox cofactors in the cytoplasm before export,
such as FeS and molybdopterin centers (5, 6). These proteins must fold
to a large extent in the cytoplasm, precluding export by the Sec machinery which is known to translocate proteins in a largely unfolded
state (reviewed in Ref. 7). In both bacteria and thylakoids, the Tat
system recognizes substrates bearing N-terminal signal peptides
containing an invariant twin-arginine motif (8, 9).
Studies on plant (10-12) and E. coli mutants (13-16) have
led to the identification of several genes encoding Tat components. Four tat genes have been characterized in E. coli, three of which (tatABC) form an operon while the
fourth gene (tatE) is monocistronic. Knockout studies have
shown that Tat-dependent export requires minimally TatB
(13, 14), TatC (15), and either TatA or TatE (14, 16). Of the latter
two components, TatA is more important than TatE, possibly due to a
much greater abundance (16). Additional tat genes have not
been identifed to date and a complex of 600 kDa comprising only TatA,
-B, and -C has been recently purified from solubilized E. coli membranes (17). However, the activity of this complex has yet
to be tested and the existence of further Tat subunits cannot be ruled
out at this stage.
Sequence analyses and biochemical analyses of the Tat subunits indicate
that TatA, -B, and -E contain a single transmembrane span with a small
C-terminal domain exposed on the cis face of the membrane
(i.e. the cytoplasm in bacteria, or stroma in chloroplasts (11)), whereas TatC is predicted to contain 6 transmembrane regions
with the N and C termini localized in the cytoplasm. There is
convincing evidence that the N terminus of TatC is indeed in the
cytoplasm since a TatBC fusion protein is active (17) and the N
terminus of the TatC domain is linked to the C terminus of TatB in this
construct. The N-terminal domain of chloroplastic TatC is, furthermore,
exposed on the stromal face of the thylakoid membrane (18).
We presently know little about the mechanism of the Tat system but the
first details on the organization of the complex are starting to
emerge. In E. coli, it was shown that TatB and TatC form a
structural and functional unit in a 1:1 ratio within the Tat complex,
and a translational fusion between the proteins was shown to be fully
functional (17). Studies on the thylakoidal homologs of these proteins,
Hcf106 and cpTatC (19), strongly suggest that these proteins likewise
function together and it was also shown that these proteins are very
likely to form the initial binding site for the docking of
Tat-dependent precursor proteins. However, the important
elements of the TatC protein have yet to be defined and in this study
we have addressed this point through a mutagenesis study. We show that
two cytoplasmic domains are highly important for the function of
E. coli TatC.
Bacterial Strains, Plasmids, and Growth Conditions--
E.
coli strain MC4100 (20) was the parental strain;
Site-specific mutagenesis was used to generate a vector that encoded
the tat operon within pBAD-ABC with point mutations in the
tatC gene, using the QuikChangeTM mutagenesis
system (Strategene) according to the manufacturer's instructions. For
studies on the effects of these mutations on green fluorescent protein
(GFP) export, these tatABC sequences were removed from
pBAD-ABC using NheI and XbaI, and cloned into the
pEXT22 vector (25) using the XbaI site, generating pEXT-ABC and mutant derivatives which are compatible with pJDT1 encoding TorA-GFP (see text below).
Cell Fractionations--
Cells were grown aerobically (in lsLB)
or anaerobically (in lsLB-GT) in medium in the presence or absence of
IPTG or arabinose (as stated in the text), and periplasm and
spheroplasts were prepared by the EDTA/lysozyme/cold osmoshock
procedure (26). Spheroplasts were lysed by sonication, and intact cells
and cellular debris were removed by centrifugation (5 min at
10,000 × g). Membranes were separated from the
cytoplasmic fraction by centrifugation (30 min at 25,0000 × g). Protein concentration was determined using a BCA-linked
assay (Pierce). Protein fractions were either separated on a 10%
nondenaturing polyacrylamide gel and analyzed for TorA activity (6) or
were separated by SDS-polyacrylamide gel electrophoresis and
immunoblotted with specific antibodies to GFP
(CLONTECH) and horseradish peroxidase anti-rabbit
IgG conjugates, using the ECL detection system (Amersham Biosciences
Inc.).
Structures of TatC Proteins--
An alignment of several bacterial
TatC proteins and the chloroplast TatC from Arabidopsis
thaliana is shown in Fig. 1, with the predicted membrane-spanning regions shaded and identical residues denoted by asterisks. The figure also illustrates 9 residues (also shaded) that are conserved in at least 30 of the 31 bacterial and plastid TatC sequences available in the data base. The
predicted topology of the protein is illustrated in Fig.
2. Given that chloroplast TatC appears to
play a role in binding of precursor proteins, we reasoned that a
cytoplasmic domain(s) in TatC may mediate this process in E. coli.
TatC proteins are not particularly highly conserved but analysis of
Fig. 1 shows that two cytoplasmically exposed loops contain a number of
highly conserved residues, whereas periplasmic loops contain few
invariant residues. A few conserved residues are present in the
transmembrane spans, but these were not examined in this study. The
extreme cytoplasmic N-terminal region and the (predicted) first
cytoplasmic loop, in particular, contain a range of conserved charged
residues; these are indicated as cytoplasmic domains 1 and 2 (CD1 and
CD2) in Fig. 1. These are more highly conserved than is immediately
apparent because Arg or Lys is present at the positions corresponding
to Arg104 and Arg105 in every other
bacterial/plastid TatC sequence, with the exception of Odontella
sinensis and Staphylococcus aureus, which lack one of
the basic residues in these positions. Plant mitochondrial TatC
proteins likewise contain only a single basic residue at these
positions in some cases. Arg is present at the position corresponding
to Arg17 in all but four of the 31 TatC sequences, where
Lys is present instead.
The significance of these residues was tested using site-specific
mutagenesis. As detailed under "Experimental Procedures," we
mutated the tatC gene within the tatABC operon in
the arabinose-inducible pBAD24 plasmid (plasmid pBAD-ABC), and
expressed this vector in a
The mutant TatC proteins were expressed after induction with arabinose
and their levels were analyzed by immunoblotting using antibodies to
TatA, TatB, and the Strep II tag on TatC. Fig.
3 shows a representative immunoblot of
cell extracts from approximately half of the mutants, which illustrates
that the various strains all contain similar levels of Tat components,
indicating that the tatABC operon is induced to similar
extents. Similar findings were made using the other mutants (data not
shown). When induced in this manner, the pBAD24 system leads to an
about 10-fold overproduction of TatABC (17) which means that the Tat
components are effectively present in excess. The effects of the
mutations on Tat-dependent export were assessed using
several criteria as explained below.
Mutations in TatC That Block Anaerobic Growth on TMAO Minimal
Media--
A standard means of assaying for Tat-dependent
export in E. coli is to test for anaerobic growth on TMAO
minimal media (11-14). The periplasmic molybdopterin-containing
protein TMAO-reductase (TorA) is a known Tat substrate (6, 11) and
tat mutants are accordingly unable to grow using TMAO as an
electron acceptor during anaerobic respiration. It should be
emphasized, however, that this assay selects only for a complete lack
of functional Tat system. Null mutations in tatAE, tatB, or
tatC are completely unable to grow but we found that the
pBAD-ABC plasmid in the
Table I shows the results of this
analysis, together with a summary of the export capabilities of these
strains (see below). In fact, our results show that very few of these
highly conserved residues are essential for Tat function, and the
majority of these strains grow at normal rates. However, substitution
of either Arg17 led to a complete loss of growth,
suggesting an important function of this (predicted) cytoplasmically
exposed region as shown in Fig. 2. In view of the apparent importance
of the CD1 region we tested the effects of deleting Leu20
to Asn22, and this mutant (
Perhaps surprisingly, a series of other highly conserved residues are
not essential for Tat function. His12, Glu15,
and Arg19, for example, are all present in cytoplasmic
domain 1 and are essentially invariant throughout bacterial and plastid
TatC sequences, yet their substitution by Ala (or Gln in the case of
Glu15) has no detectable effect. In cytoplasmic domain 2, while substitution of Arg104 does inhibit growth,
substitution of Arg105 by Ala has no detectable effect on
growth even though a basic residue is present at this position in the
vast majority of bacterial and plastid TatC sequences (although this
mutant is affected in export of torA-GFP; see below). Even more
surprisingly, Pro97 is one of the few invariant residues
but its substitution again fails to impair anaerobic growth. Relatively
few residues on the periplasmic side were targeted for mutagenesis in
this study, but it is notable that substitution of Pro48
blocks growth entirely, suggesting an important function for this residue.
Several tatC Mutants Are Unable to Export Either TorA or
TorA-GFP--
To analyze more directly the consequences of the
tatC mutations, we next analyzed the distribution of a known
Tat substrate, TorA, in cells expressing the various mutant forms. This
was achieved using native gels in which the TorA activity is visualized
directly in the polyacrylamide gel, using a methyl viologen-linked
assay. Fig. 4 shows that the vast
majority of active TorA is localized in the periplasm in wild-type
cells expressing the pBAD-ABC vector (pBAD-ABC panel) as shown
previously (22). The results obtained with the mutant strains, in
general, agree with the data from the anaerobic growth analysis. Those
tatC mutants that fail to grow anaerobically (R17A,
In general, this assay should be more sensitive than the
anaerobic growth test and Tat-dependent export defects are
indeed more apparent in other cases. The L20A mutant, in particular, exhibited slow growth on TMAO miminal media but Fig. 4 shows that the
TorA export is in fact drastically affected with most of the activity
present in the cytoplasm. Accumulation of the cytoplasmic TorA*
species is also evident with two other mutants, L16A and R105A. Both
residues are in the conserved cytoplasmic domains and, in the case of
R105A as discussed above, a charged residue is highly conserved among
bacterial TatC proteins. These mutations do, therefore, affect TatC function.
As a final test we examined the export of a chimeric protein comprising
the presequence of TorA linked to GFP. Previous studies (23, 28)
have shown this construct to be exported exclusively by the Tat pathway
and GFP represents a much simpler export substrate than TorA, because
it does not acquire an additional cofactor before export. Another
important point is that the export of this protein is examined over a
much shorter time scale. One disadvantage of the TorA assay is that
only steady-state levels can be analyzed, and this can mean that
defects in the TatC operation can be masked because the cells have
sufficient time to export the protein even when the Tat system is
functioning suboptimally. In contrast, the TorA-GFP is rapidly induced
at fairly high levels, after which the Tat system is expressed and the
cells are fractionated within a few hours. Under these conditions,
effects on export rates are more likely to be apparent. (Ideally,
the GFP would be analyzed using pulse-chase techniques which give a
much better picture of the export kinetics. However, we have been
unable to apply this technique to GFP export because the
immunoprecipitation is ineffective, for unknown reasons.) To examine
the export of this construct, we used a growth regime in which
expression of the TorA-GFP was induced by arabinose, after which the
Fig. 5 shows that expression of the
wild-type tatABC operon (pEXT-ABC panel) results in export
of the TorA-GFP and the vast majority of the GFP is found in the
periplasmic fraction (lane P) as the mature form.
Essentially no TorA-GFP is apparent in the membrane fraction
(M) and very little mature-size GFP is apparent in the
cytoplasmic fraction (C). Previous work on the export of this construct (23) also found that the cytoplasmic GFP was primarily
mature-size, presumably due to proteolysis of the signal peptide.
Otherwise, the results obtained using the tatC mutants closely resemble those obtained from the TorA analysis. Export of
TorA-GFP in the R17A, In this report we have aimed to provide a first dissection of the
E. coli TatC protein to begin mapping the important regions. The TatC family is in fact remarkably poorly conserved in terms of
primary sequence, and the actual sequence data provide very few clues
as to its role in Tat-dependent protein export. This lack
of sequence conservation is all the more surprising given the highly
conserved nature of the translocation mechanism as well as the
targeting signals that are recognized by this system. For example,
chloroplast thylakoids can recognize and import E. coli Tat
substrates as efficiently as those of their cognate substrates (29,
30). While the precise role of TatC still requires detailed study, the
available data indicate that (a) it functions together with
TatB (or Hcf106 in chloroplasts) and (b) it may form part of
the initial binding site for precursor proteins (17, 19).
Relatively few TatC residues are invariant even among eubacteria
and in this study we have mutated the majority of conserved residues
located in either the cytoplasmic or periplasmic loop regions. In fact,
many of these mutations have no drastic effect on TatC function,
although it must be stressed that kinetic analyses on export rates may
reveal minor effects that are not evident from the types of analysis
used here. However, it is notable that a high proportion of these
highly conserved residues are located in the two cytoplasmic domains
described in this report, and we have now shown that mutations in
several of these residues lead to an absolute block in Tat function.
None of the mutations affect Tat subunit stability to any detectable
extent, and we therefore propose that these data point to the presence
of two essential cytoplasmic domains in the TatC protein. Of course, it
is possible that these two areas of the protein function together as a
single functional domain. We emphasize that the data do not indicate how these domains function and, while they may well form a critical binding site for incoming precursor proteins, it is also possible that
these mutations destabilize the TatABC complex and hence affect
translocation in a more indirect manner.
These data now pave the way for more detailed studies on the roles of
the individual domains in TatC function. A recent report (31) has
described an in vitro assay for Tat-dependent
import into inverted E. coli inner membrane vesicles, and
studies on the thylakoid system (19) have shown that Tat substrates can bind to the Tat complex under appropriate conditions. It should therefore be possible to use such techniques to determine in detail the
function of individual residues and domains in TatC, in terms of either
substrate binding or the subsequent translocation mechanism.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
SUMMARY
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
SUMMARY
REFERENCES
tatAE,
tatB,
tatC, and
tatABCDE have been described before (14, 15, 21), and
arabinose-resistant derivatives were used as described (22). Plasmid
pBAD-ABC has been described before (22). E. coli was
aerobically grown at 37 °C in modified low salt Luria broth (lsLB)
(23). E. coli was grown anaerobically in lsLB-GT medium,
consisting of lsLB supplemented with glycerol (0.5%), trimethylamine
N-oxide (TMAO; 0.4%), and ammonium molybdate (1 µM), or in minimal TMAO/glycerol medium (22). Media
supplements were used at the following final concentrations:
ampicillin, 100 µg/ml; kanamycin, 50 µg/ml; 1 mM
isopropyl-
-D-thiogalactopyranoside (IPTG); 200 µM arabinose.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
SUMMARY
REFERENCES

View larger version (79K):
[in a new window]
Fig. 1.
Alignment of bacterial and
Arabidopsis TatC proteins. The alignment was
performed using the TatC sequences from E. coli
(E.c.), Hemophilus influenzae (H.i),
Rickettsia prowazekii (R.p), Aquiflex
aeolicus (A.a), Helicobacter pylori
(H.p), Synechocystis PCC 6803 (Syn),
and A. thaliana (A.t; the chloroplastic
sequence). Predicted transmembrane (TM) spans are indicated
and shown shaded, identical residues are denoted by
asterisks, and conserved residues by dots. The
figure also highlights 9 residues that are either absolutely conserved,
or nearly so, in an alignment of 31 bacterial and plastid TatC proteins
(see text). Residues mutated in this study are shown in bold
and the two conserved cytoplasmic domains (CD1 and CD2) are indicated
by boxes.

View larger version (24K):
[in a new window]
Fig. 2.
Predicted topology of E. coli
TatC. The diagram shows the 6-span topology of the E. coli TatC protein predicted using the TopPred II algorithm (32)
and the positions of the residues targeted for analysis in this study.
Shaded residues represent those that exhibit major defects
in Tat-dependent export when mutated as described in this
study.
tatABCDE background. The TatC
protein encoded by this plasmid contains a C-terminal Strep II tag
which does not affect activity, and expression of pBAD-ABC in this
background leads to efficient Tat-dependent export (22).
The targeted residues are shown in bold in the alignment in Fig. 1 and
their predicted positions are illustrated in Fig. 2. Most of the
mutations were to Ala but Glu15 and Glu103 were
changed to Gln. The reason for this strategy was that these residues
were considered as candidates for binding the positively charged
twin-arginine signal peptide of TorA, and we sought to remove the
negative charge but retain the side chain properties as far as possible.

View larger version (72K):
[in a new window]
Fig. 3.
Tat subunit levels in strains expressing TatC
mutants. E. coli
tatABCDE strains expressing
tatABC (lane pBAD-ABC) and tatC
mutants were grown to equivalent optical densities and analyzed by
SDS-polyacrylamide gel electrophoresis followed by immunblotting using
antibodies to TatA, TatB, or to the Strep II tag present on TatC.
tatABCDE strain supported
anaerobic growth even without induction, when levels of TatABC were
almost undetectable (17, 22). Clearly, even very low levels of the Tat
apparatus are sufficient to support growth on TMAO minimal medium.
20-22) was again completely
unable to grow under these conditions.
Export characteristics of E. coli TatC mutants
20-22, and P48A) are also unable to export TorA and the activity is
found almost exclusively in the cytoplasmic fraction. The cytoplasmic
TorA has a reduced mobility in this gel system (denoted TorA*),
possibly due to the presence of the presequence but more likely due to
other effects on folding or binding to other factors, since the
presequence is small compared with the 86-kDa mature protein. In the
case of R17A, no activity whatsoever is evident in the periplasmic
fraction, confirming the central importance of this residue. With
20-22, a very low proportion of the TorA activity is apparent in
the periplasmic fraction but the vast majority of TorA is again present
as the cytoplasmic species.

View larger version (50K):
[in a new window]
Fig. 4.
Localization of TMAO reductase activity in
cells expressing TatC mutants. E. coli MC4100
cells containing the pBAD24 vector, or
tatABCDE cells
expressing mutations in the tatC within pBAD-ABC were grown
anaerobically and then fractionated to generate cytoplasmic and
periplasmic fractions (C and P) as detailed under
"Experimental Procedures." The samples were analyzed by native gel
electrophoresis and TMAO reductase activity was visualized in the gel.
Mature-size TorA is indicated and TorA* denotes
lower-mobility cytoplasmic form.
tatABCDE cells were washed and incubated with IPTG to
induce expression of the tatABC operon from the pEXT22
plasmid. The localization of the GFP was monitored by immunoblotting.
20-22, and P48A mutants is drastically affected and the majority of GFP is found in the cytoplasmic and membrane fractions. Export is also affected in the R104A and R105A mutants, confirming the importance of this conserved domain. The one
surprise is L20A, which exports torA-GFP with high efficiency, yet
which fails to export TorA except at low levels. The reason for this
finding is currently under study. These data are summarized in Table
I.

View larger version (25K):
[in a new window]
Fig. 5.
Effects of tatC mutations on export of
TorA-GFP. All strains contained plasmid pJDT1 encoding TorA-GFP in
the pBAD24 vector (23). As a control, wild-type MC4100 cells contained
in addition plasmid pEXT-ABC (encoding the wild-type tatABC
operon; panel pEXT-ABC) and the remaining panels represent
tatABCDE cells containing the same vector with mutated
tatC genes. Expression of TorA-GFP was induced using
arabinose, after which expression of TatABC was induced using IPTG as
detailed under "Experimental Procedures." Cells were fractionated
to yield cytoplasmic (C), membrane (M), and
periplasmic (P) samples and immunoblotted using antibodies
to GFP. Mature-size GFP and the TorA-GFP precursor protein are
indicated.
![]()
SUMMARY
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
SUMMARY
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by Biotechnology and Biological Sciences Research Council Grants E13320 and P15253 (to C. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 44-2476-523557;
Fax: 44-2476-523701; E-mail: Crobinson@bio.warwick.ac.uk.
Published, JBC Papers in Press, January 7, 2002, DOI 10.1074/jbc.M109135200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Tat, twin-arginine translocation;
lsLB, low salt Luria broth;
TMAO, trimethylamine N-oxide;
IPTG, isopropyl-
-D-thiogalactopyranoside;
GFP, green
fluorescent protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Robinson, C.,
and Bolhuis, A.
(2001)
Nat. Rev. Mol. Cell. Biol.
2,
350-355[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Dalbey, R. E.,
and Kuhn, A.
(2000)
Annu. Rev. Cell Dev. Biol.
16,
51-87[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Clark, S. A.,
and Theg, S. M.
(1997)
Mol. Biol. Cell
8,
923-934[Abstract] |
| 4. |
Hynds, P. J.,
Robinson, D.,
and Robinson, C.
(1998)
J. Biol. Chem.
273,
34868-34874 |
| 5. |
Berks, B. C.
(1996)
Mol. Microbiol.
22,
393-404[CrossRef][Medline]
[Order article via Infotrieve] |
| 6. |
Santini, C.-L.,
Ize, B.,
Chanal, A.,
Müller, M.,
Giordano, G.,
and Wu, L.-F.
(1998)
EMBO J
17,
101-112[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. |
Manting, E. H.,
and Driessen, A. J.
(2000)
Mol. Microbiol.
37,
226-238[CrossRef][Medline]
[Order article via Infotrieve] |
| 8. |
Chaddock, A. M.,
Mant, A.,
Karnauchov, I.,
Brink, S.,
Herrmann, R. G.,
Klösgen, R. B.,
and Robinson, C.
(1995)
EMBO J.
14,
2715-2722[Medline]
[Order article via Infotrieve] |
| 9. |
Stanley, N. R.,
Palmer, T.,
and Berks, B. C.
(2000)
J. Biol. Chem.
275,
11591-11596 |
| 10. |
Voelker, R.,
and Barkan, A.
(1995)
EMBO J.
14,
3905-3914[Medline]
[Order article via Infotrieve] |
| 11. |
Settles, M. A.,
Yonetani, A.,
Baron, A.,
Bush, D. R.,
Cline, K.,
and Martienssen, R.
(1997)
Science
278,
1467-1470 |
| 12. |
Walker, M. B.,
Roy, L. M.,
Coleman, E.,
Voelker, R.,
and Barkan, A.
(1999)
J. Cell Biol.
147,
267-276 |
| 13. |
Weiner, J. H.,
Bilous, P. T.,
Shaw, G. M.,
Lubitz, S. P.,
Frost, L.,
Thomas, G. H.,
Cole, J. A.,
and Turner, R. J.
(1998)
Cell
93,
93-101[CrossRef][Medline]
[Order article via Infotrieve] |
| 14. |
Sargent, F.,
Bogsch, E. G.,
Stanley, N. R.,
Wexler, M.,
Robinson, C.,
Berks, B. C.,
and Palmer, T.
(1998)
EMBO J.
17,
3640-3650[CrossRef][Medline]
[Order article via Infotrieve] |
| 15. |
Bogsch, E. G.,
Sargent, F,
Stanley, N. R.,
Berks, B. C.,
Robinson, C.,
and Palmer, T.
(1998)
J. Biol. Chem.
273,
18003-18006 |
| 16. |
Sargent, F.,
Stanley, N. R.,
Berks, B. C.,
and Palmer, T.
(1999)
J. Biol. Chem.
274,
36073-36082 |
| 17. |
Bolhuis, A.,
Mathers, J. E.,
Thomas, J. D.,
Barrett, C.,
and Robinson, C.
(2001)
J. Biol. Chem.
276,
20213-20219 |
| 18. |
Mori, H.,
Summer, E. J.,
and Cline, K.
(2001)
FEBS Lett.
501,
65-68[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Cline, K.,
and Mori, H.
(2001)
J. Cell Biol.
154,
719-729 |
| 20. |
Casadaban, M. J.,
and Cohen, S. N.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4530-4533 |
| 21. |
Wexler, M.,
Sargent, F.,
Jack, R. L.,
Stanley, N. R.,
Bogsch, E. G.,
Robinson, C.,
Berks, B. C.,
and Palmer, T.
(2000)
J. Biol. Chem.
275,
16717-16722 |
| 22. |
Bolhuis, A.,
Bogsch, E. G.,
and Robinson, C.
(2000)
FEBS Lett.
472,
88-92[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Thomas, J. D.,
Daniel, R. A.,
Errington, J.,
and Robinson, C.
(2001)
Mol. Microbiol.
39,
47-52[CrossRef][Medline]
[Order article via Infotrieve] |
| 24. | Deleted in proof |
| 25. |
Dykxhoorn, D. M., St.,
Pierre, R.,
and Linn, T.
(1996)
Gene (Amst.)
177,
133-136[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Randall, L. L.,
and Hardy, S. L. S.
(1986)
Cell
46,
921-928[CrossRef][Medline]
[Order article via Infotrieve] |
| 27. | Deleted in proof |
| 28. |
Santini, C-L.,
Bernadac, A.,
Zhang, M.,
Chanal, A.,
Ize, B.,
Blanco, C.,
and Wu, L-F.
(2001)
J. Biol. Chem.
276,
8159-8164 |
| 29. |
Wexler, M.,
Bogsch, E. G.,
Palmer, T.,
Robinson, C.,
and Berks, B. C.
(1998)
FEBS Lett.
431,
339-342[CrossRef][Medline]
[Order article via Infotrieve] |
| 30. |
Mori, H.,
and Cline, K.
(1998)
J. Biol. Chem.
273,
11405-11408 |
| 31. |
Yahr, T. L.,
and Wickner, W. T.
(2001)
EMBO J.
20,
2472-2479[CrossRef][Medline]
[Order article via Infotrieve] |
| 32. |
Claros, M. G.,
and von Heijne, G.
(1994)
Comput. Appl. Biosci.
10,
685-686 |
This article has been cited by other articles:
![]() |
C. Punginelli, B. Maldonado, S. Grahl, R. Jack, M. Alami, J. Schroder, B. C. Berks, and T. Palmer Cysteine Scanning Mutagenesis and Topological Mapping of the Escherichia coli Twin-Arginine Translocase TatC Component J. Bacteriol., August 1, 2007; 189(15): 5482 - 5494. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schreiber, R. Stengel, M. Westermann, R. Volkmer-Engert, O. I. Pop, and J. P. Muller Affinity of TatCd for TatAd Elucidates Its Receptor Function in the Bacillus subtilis Twin Arginine Translocation (Tat) Translocase System J. Biol. Chem., July 21, 2006; 281(29): 19977 - 19984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gouffi, F. Gerard, C.-L. Santini, and L.-F. Wu Dual Topology of the Escherichia coli TatA Protein J. Biol. Chem., March 19, 2004; 279(12): 11608 - 11615. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Palmer and B. C. Berks Moving folded proteins across the bacterial cell membrane Microbiology, March 1, 2003; 149(3): 547 - 556. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |